This is a Phase 3, multi-center, randomized, open-label, assess-blind study to determine the efficacy and safety of MLT, a novel antibiotic lock therapy that combines minocycline with edetate disodium in 25% ethanol solution as an adjuctive therapy…
- Investigator
- Gary P Wang
- Status
- Accepting Candidates
- Ages
- 12 Years - N/A
- Sexes
- All